Stacy Markel's most recent trade in Nuvation Bio Inc - Ordinary Shares - Class A was a trade of 125,000 Class A Common Stock done at an average price of $6.0 . Disclosure was reported to the exchange on June 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Sale of securities on an exchange or to another person at price $ 6.03 per share. | 23 Jun 2026 | 125,000 | 32,591 | - | 6.0 | 753,188 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 23 Jun 2026 | 90,380 | 122,971 | - | 1.9 | 169,011 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2026 | 90,380 | 409,620 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 23 Jun 2026 | 34,620 | 157,591 | - | 1.7 | 60,239 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2026 | 34,620 | 220,190 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 748,130 | 748,130 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 18 Jun 2025 | 10,000 | 29,591 | - | 1.7 | 17,100 | Class A Common Stock |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Stacy Markel | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) |